Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Baricitinib is effective for severe alopecia areata but has some side effects.

Silibinin may help hair growth and treat hair loss.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Baricitinib is an effective treatment for severe alopecia areata.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

The higher dose supplement was more effective in treating female hair loss.

The combination therapy improved severe alopecia areata in a patient after 14 days.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

The serum improved hair growth and condition after hair transplant.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

TCM is an effective and safe treatment for primary cicatricial alopecias.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Biological therapy boosts the immune system to effectively fight melanoma.